Veena Mani And Sohini Das

Stories by Veena Mani And Sohini Das

Can Vodafone Idea reap synergy benefits?

Can Vodafone Idea reap synergy benefits?

Rediff.com   23 Apr 2019

India's largest telecom operator in terms of subscriber numbers has been struggling to raise its share of subscribers in the market for fourth-generation technology services.

MNC pharma cos may be afflicted by pneumonia virus

MNC pharma cos may be afflicted by pneumonia virus

Rediff.com   22 Apr 2019

Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.

Why Jio may now have to buy spectrum from the open market

Why Jio may now have to buy spectrum from the open market

Rediff.com   20 Apr 2019

While the company insisted it had enough spectrum across circles, analysts said the company might soon need to acquire some spectrum to ensure uninterrupted service.

Raymond forays into real estate with Thane project

Raymond forays into real estate with Thane project

Rediff.com   4 Apr 2019

The project will house 3,000 residential units across 10 towers in the first phase on a 20-acre land parcel that Raymond owns in Thane

Why cold wave across US is good news for Indian drug cos

Why cold wave across US is good news for Indian drug cos

Rediff.com   12 Mar 2019

Companies such as Cadila Healthcare, Lupin, and Natco, which sell generic versions of flu medication in the US market, are likely to benefit.

Jio likely to grab 51% revenue market share in 3 years

Jio likely to grab 51% revenue market share in 3 years

Rediff.com   7 Jan 2019

Airtel and Vodafone Idea are also trying to expand the penetration of 4G users in their subscriber base as they take this network to the hinterland

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com   6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

Modicare covers basics, but complex healthcare mostly outside ambit

Modicare covers basics, but complex healthcare mostly outside ambit

Rediff.com   4 Dec 2018

Among the most widely used packages have been treatment of cataract, dental root canal and normal delivery of babies.

Panel says Big 4 auditing firms are not 'multinationals'

Panel says Big 4 auditing firms are not 'multinationals'

Rediff.com   12 Nov 2018

'These firms do not contravene provisions of Chartered Accountants Act, 1949, which bar members of the countries not allowing Indians to practice accountancy in their jurisdiction to become chartered accountants in India,' said the committee, headed by Anurag Agarwal, a joint secretary in the ministry of corporate affairs, and such Indian audit firms cannot be equated with multi-national corporations.

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Rediff.com   9 Nov 2018

Singh, who was instrumental in building required capabilities in the organisation said his role at Fortis did not allow him to spend time with his family, as the reason behind his resignation.

MCA likely to cap fees of independent directors

MCA likely to cap fees of independent directors

Rediff.com   7 Nov 2018

The ministry said some urgent amendments are not there in the ordinance but are required for strengthening the corporate governance

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com   1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

Why drug firms' Q2 revenue growth is likely to dip

Why drug firms' Q2 revenue growth is likely to dip

Rediff.com   12 Oct 2018

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com   10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

Why draft pharma policy may take time to see light of day

Why draft pharma policy may take time to see light of day

Rediff.com   25 Sep 2018

Some of the proposals (for example trade margin calculation for imported medical devices) were not approved by the PMO and were sent back for revisions.

How Amul is quelling the 'non-veg' rumours

How Amul is quelling the 'non-veg' rumours

Rediff.com   21 Sep 2018

This is not the first time Gujarat Cooperative Milk Marketing Federation that owns brand Amul has chosen an unconventional method to protect its brand.

Govt plans to bring another 100,000 firms out of their shells

Govt plans to bring another 100,000 firms out of their shells

Rediff.com   17 Sep 2018

In the second phase of action against shell companies, the MCA is also trying to trace the directors of 'vanishing' companies

For Singh brothers, truce is temporary, split only way out

For Singh brothers, truce is temporary, split only way out

Rediff.com   15 Sep 2018

NCLT allows Shivinder to withdraw petition against his brother Malvinder. Final decision to be taken by family members in their presence.

Shivinder vs Malvinder: Mother helps avoid legal battle for now

Shivinder vs Malvinder: Mother helps avoid legal battle for now

Rediff.com   14 Sep 2018

Sources said she had stopped eating for the past few days and had constantly been making calls and sending emails to the two brothers.

Where the health of Ayushman Bharat is in a shambles

Where the health of Ayushman Bharat is in a shambles

Rediff.com   14 Sep 2018

From coming up with the correct list of beneficiaries to finding enough people to work as Ayushman Mitras to generating awareness about the scheme - many things need to fall in place before it can be successfully launched in a few days.